PEN insider trading
NYSE HealthcarePenumbra Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Company website: www.penumbrainc.com
PEN insider activity at a glance
FilingIQ has scored 1,754 insider transactions for PEN since Jan 2, 2016. The most recent filing in our index is dated Apr 2, 2026.
Across the full history, 2 open-market purchases
and 1,408 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PEN insider trades is 57.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PEN Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding PEN
Frequently asked
- How many insider trades does FilingIQ track for PEN?
- FilingIQ tracks 1,754 Form 4 insider transactions for PEN (Penumbra Inc), covering filings from Jan 2, 2016 onwards. 14 of those were filed in the last 90 days.
- Are PEN insiders net buyers or net sellers?
- Across the full Form 4 history for PEN, 2 transactions (0%) were open-market purchases and 1,408 (80%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PEN insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is PEN in?
- Penumbra Inc (PEN) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $13.31B.
Methodology & sources
Every PEN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.